iRhythm的Zio监测服务显示,与其他心脏监测方法相比,诊断结果和患者的参与情况较好。 iRhythm's Zio monitoring service shows better diagnostic results and patient engagement than other cardiac monitoring methods.

i Rythm Technology在心脏节奏协会2025年会议上提供了数据,表明其Zio长期持续监测服务与其他监测服务相比,诊断收成较高,再测试较少,心血管事件发生率较低。 iRhythm Technologies presented data at the Heart Rhythm Society's 2025 conference, showing that its Zio long-term continuous monitoring (LTCM) service has a higher diagnostic yield, fewer retests, and lower cardiovascular event rates compared to other monitoring services. 该公司的MyZio App也改善了患者的症状报告与参与。 The company's MyZio App also improved patient symptom reporting and engagement. 这些调查结果支持数字健康工具在心脏监测方面的有效性。 These findings support the effectiveness of digital health tools in cardiac monitoring.